OXIGENE INC·4

Apr 29, 6:59 PM ET

LANGECKER PETER 4

4 · OXIGENE INC · Filed Apr 29, 2010

Insider Transaction Report

Form 4
Period: 2010-04-27
LANGECKER PETER
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2010-04-27+400,000400,000 total
    Exercise: $1.06From: 2010-10-27Exp: 2020-04-27Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]The Stock Options will vest in eight equal semi-annual installments over four years beginning six months from the grant date.

Documents

1 file
  • 4
    rrd273839.xmlPrimary

    FORM 4 - STOCK OPTIONS